Cryotherapy is one of the most accessible effective treatments for equine sarcoids and provides good welfare outcomes for many tumor types and locations.
Cryotherapy for equine sarcoids offers a welfare-friendly treatment option for accessible tumors with acceptable response rates. Unlike surgical excision, which carries significant recurrence risk due to incomplete margins and tumor cell seeding, cryotherapy avoids cutting through tumor tissue and reduces recurrence risk for responsive tumor types. The procedure causes local discomfort during treatment but is manageable under local anaesthesia. Post-treatment tissue necrosis and sloughing require wound management but is self-limiting. The welfare benefit of successful cryotherapy treatment - eliminating a potentially uncomfortable or function-limiting tumor - is substantial. Appropriate case selection (tumor type, location, and size) is critical for good welfare outcomes; referral to an experienced clinician improves success rates.